Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,697-9,708 of 10,661

Drug study icon

CompletedNCT00535002

The Effect of Yohimbine on Cocaine Cue Reactivity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Behavioral study icon

CompletedNCT00466323

The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, DepressionBehavioralFrom 18 Years to 70 Years

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: Schizophrenia, Depression

Behavioral study icon

CompletedNCT06669442

The Effectiveness of Guided Imagery on PCL-5 Scores in Adult Women With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 99 Years

Countries: United States
Sponsor: Nova Southeastern University
Condition: PTSD

Device study icon

CompletedNCT01191333

The Effectiveness of rTMS in Depressed VA Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDeviceFrom 18 Years to 80 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Depression

Drug study icon

CompletedNCT00986531

The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: AstraZeneca
Condition: Schizophrenia

Drug study icon

CompletedNCT01591629

The Effects of ∆-9-THC and Naloxone in Humans

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Behavioral study icon

CompletedNCT06403514

The Effects of a Psychoeducational Intervention on Health and Performance-based Outcomes of Veterans Diagnosed With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Nova Southeastern University
Condition: PTSD

Drug study icon

CompletedNCT02293655

The Effects of ADHD Medication (TEAM) Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 7 Years to 11 Years

Countries: United States
Sponsor: Children's Hospital Medical Center, Cincinnati
Condition: ADHD

Drug study icon

CompletedNCT00224822

The Effects of Aripiprazole on people with Metabolic Syndrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: New Mexico VA Healthcare System
Condition: Schizophrenia, Bipolarity

Drug study icon

TerminatedNCT00209027

The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 20 Years to 50 Years

Countries: United States
Sponsor: Emory University
Condition: Schizophrenia

Drug study icon

TerminatedNCT00548327

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Schizophrenia

Drug study icon

CompletedNCT01180374

The Effects of Cannabidiol and ∆-9-THC in Humans

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.